Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (GB:0K1R)
LSE:0K1R
RESEARCH TOOLSreports
Viridian Therapeutics (0K1R) Ownership - Who Owns Viridian Therapeutics?
0 Followers
Viridian Therapeutics (0K1R) Ownership Overview
36.25% Insiders
23.10% Mutual Funds
18.03% Other Institutional Investors
22.62% Public Companies and
Individual Investors
The ownership structure of Viridian Therapeutics (GB:0K1R) stock is a mix of institutional, retail and individual investors. Approximately 41.13% of the company’s stock is owned by Institutional Investors, 36.25% is owned by Insiders and 22.62% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 24, 2024 | Fairmount Funds Management Llc Director, >10% Owner | Bought | $9999990 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $631 | |
| Dec 31, 2023 | Bought | $37684017 | |
| Dec 31, 2023 | Bought | $50656816 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,378,918 | Institution | 5.38% | 43,533,980 | |
| 2,986,365 | Institution | 4.76% | 38,476,327 | |
| 2,472,325 | Institution | 3.94% | 31,853,435 | |
| 2,325,841 | Institution | 3.71% | 29,966,135 | |
| 2,237,629 | Insider | 3.56% | 28,829,612 | |
| 2,219,238 | Institution | 3.54% | 28,592,662 | |
| 2,034,907 | Institution | 3.24% | 26,217,742 | |
| 2,007,946 | Institution | 3.20% | 25,870,376 | |
| 1,928,050 | Institution | 3.07% | 24,840,996 | |
| 1,847,752 | Institution | 2.94% | 23,806,437 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,472,325 | Institution | 3.94% | 31,853,435 | |
| 2,219,238 | Institution | 3.54% | 28,592,662 | |
| 2,034,907 | Institution | 3.24% | 26,217,742 | |
| 1,847,752 | Institution | 2.94% | 23,806,437 | |
| 957,805 | Institution | 1.53% | 12,340,360 | |
| 689,812 | Institution | 1.10% | 8,887,538 | |
| 672,500 | Institution | 1.07% | 8,664,490 | |
| 491,684 | Institution | 0.78% | 6,334,857 | |
| 458,265 | Institution | 0.73% | 5,904,286 | |
| 401,927 | Institution | 0.64% | 5,178,427 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Viridian Therapeutics (GB:0K1R)?
According to the latest TipRanks data, approximately 18.03% of the company's stock is held by institutional investors, 36.25% is held by insiders, and 22.62% is held by retail investors.
What percentage of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.03% of Viridian Therapeutics (GB:0K1R) stock is held by institutional investors.
What percentage of Viridian Therapeutics (GB:0K1R) stock is held by retail investors?
According to the latest TipRanks data, approximately 22.62% of Viridian Therapeutics (GB:0K1R) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (GB:0K1R)?
SPDR owns the most shares of Viridian Therapeutics (GB:0K1R).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.